Saturday, July 11, 2026

pharma · Advanced Solid Tumor · Advanced Solid Tumors

Multitude Therapeutics

Multitude Therapeutics clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Redwood City, USA HQ
2018 Founded
9 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Redwood City, USA
Founded
2018
Employees
9
Programs
2
Drugs
0
Patents
0
Intelligence · Clinical Programs

Multitude Therapeutics projects

2 ClinicalTrials.gov programs sponsored by Multitude Therapeutics.

Multitude Therapeutics has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. AMT-116

    Multitude Therapeutics

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial
  2. AMT-676

    Multitude Therapeutics

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Multitude Therapeutics have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.